Joshi, J., Tanner, L., Gilchrist, L., & Bostrom, B. (2019). Switching to Bortezomib may Improve Recovery From Severe Vincristine Neuropathy in Pediatric Acute Lymphoblastic Leukemia. Journal of pediatric hematology/oncology, 41(6), 457. https://doi.org/10.1097/MPH.0000000000001529
Chicago-Zitierstil (17. Ausg.)Joshi, Jaitri, Lynn Tanner, Laura Gilchrist, und Bruce Bostrom. "Switching to Bortezomib May Improve Recovery From Severe Vincristine Neuropathy in Pediatric Acute Lymphoblastic Leukemia." Journal of Pediatric Hematology/oncology 41, no. 6 (2019): 457. https://doi.org/10.1097/MPH.0000000000001529.
MLA-Zitierstil (9. Ausg.)Joshi, Jaitri, et al. "Switching to Bortezomib May Improve Recovery From Severe Vincristine Neuropathy in Pediatric Acute Lymphoblastic Leukemia." Journal of Pediatric Hematology/oncology, vol. 41, no. 6, 2019, p. 457, https://doi.org/10.1097/MPH.0000000000001529.